N -Methyl-D-Aspartate-Mediated Injury Enhances Quisqualic Acid-Stimulated Phosphoinositide Turnover in Perinatal Rats
Chen, Chu-Kuang; Silverstein, Faye Sarah; Johnston, Michael V.
1992-09
Citation
Chen, Chu-Kuang; Silverstein, Faye S.; Johnston, Michael V. (1992). " N -Methyl-D-Aspartate-Mediated Injury Enhances Quisqualic Acid-Stimulated Phosphoinositide Turnover in Perinatal Rats." Journal of Neurochemistry 59(3): 963-971. <http://hdl.handle.net/2027.42/65991>
Abstract
Previous work in our laboratory demonstrated that ischemic-hypoxic brain injury in postnatal day 7 rats causes a substantial increase in phosphoinositide (PPI) turnover stimulated by the glutamate analogue quisqualic acid (QUIS) in the hippocampus and striatum. To examine this phenomenon in more detail, we performed similar experiments after producing injury by unilateral intracerebral injections of the glutamate analogue N -methyl-D-aspartate (NMDA). The 7-day-old rodent brain is hypersensitive to NMDA neurotoxicity and NMDA injection causes histopathology that closely resembles that produced by ischemia-hypoxia. NMDA, 17 nmol in 0.5 Μl, was injected into the right posterior striatum of 7-day-old rat pups and they were killed 3 days later. Hippocampal or striatal tissue slices were prepared from ipsilateral and contralateral hemispheres from vehicle-injected control and from noninjected control rat pups. Slices were then incubated with myo -[ 3 H]inositol plus glutamate agonists or antagonists in the presence of lithium ions and [ 3 H]inositol monophosphate ([ 3 H]IP 1 ) accumulation was measured. The glutamate agonists, QUIS, L-glutamic acid, and ( RS )-Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, stimulated greater [ 3 H]IP 1 release in tissue ipsilateral to the NMDA injection compared with that in the contralateral side and in control pups. The glutamate antagonists, D,L-2-amino-7-phosphonoheptanoic acid, 3-[(+)-2-carboxypiperazin-4-yl]-propyl-l-phosphoric acid, kynurenic acid, and 6,7-dinitroquinoxaline-2,3-dione did not inhibit QUIS-stimulated [ 3 H]IP 1 release. The enhanced PPI turnover in the lesioned tissue was specific to glutamate receptors because carbachol (CARB) failed to elicit preferential enhanced stimulation. To investigate the possibility that alterations in the release of endogenous neurotransmitters had a role in potentiating QUIS-stimulated PPI turnover after NMDA injection, we examined the effect of tetrodotoxin. Tetrodotoxin (0.5 Μ M ) did not alter QUIS-or CARB-stimulated PPI hydrolysis in the lesioned or unlesioned tissue. The influence of extracellular calcium concentration on QUIS-stimulated [ 3 H]IP 1 formation was also examined after the NMDA lesion. Moderate reduction of calcium in the buffer (1 Μ M ) enhanced the lesion effect. Low calcium buffer enhanced QUIS-stimulated PPI turnover in the lesioned hippocampal slices, but reduced QUIS stimulation in contralateral slices and controls. In contrast, CARB-stimulated PPI turnover was not enhanced in low Ca 2+ buffer. A similar pattern of Ca 2+ dependency was observed in striatal slices. Calcium-free (<10 n M ) buffer suppressed PPI turnover in all groups. These studies demonstrate that NMDA-induced excitotoxic injury in neonatal rats causes a selective enhancement of QUIS-stimulated PPI turnover that resembles the effects of ischemia-hypoxia. In addition, we found that agonist-stimulated PPI turnover is sensitive to the in vitro Ca 2+ concentration. These changes could reflect altered coupling of non-NMDA receptors to phospholipase C activity.Publisher
Blackwell Publishing Ltd
ISSN
0022-3042 1471-4159
Other DOIs
PMID
1322976
Types
Article
Metadata
Show full item recordRemediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.